Hot Features
Registrieren Sie sich für Echtzeit-Charts, Analysetools und Preise.
AlloVir Inc is a late clinical-stage cell therapy company. It is developing allogeneic T cell therapies to treat and prevent devastating viral diseases. The firm's pipeline includes ALVR106, ALVR109, ALVR108, and others. The company's product candidate, Viralym-M, is a multi-VST therapy targeting fi... AlloVir Inc is a late clinical-stage cell therapy company. It is developing allogeneic T cell therapies to treat and prevent devastating viral diseases. The firm's pipeline includes ALVR106, ALVR109, ALVR108, and others. The company's product candidate, Viralym-M, is a multi-VST therapy targeting five viruses namely BK virus, cytomegalovirus, adenovirus, Epstein-Barr virus, and human herpesvirus 6. Mehr anzeigen
| Zeitraum † | Änderung | Änderung % | Handelsbeginn | Hoch | Niedrig | Durchsch. Volumen | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | -0.0415 | -7.79489105935 | 0.5324 | 0.56 | 0.4967 | 240898 | 0.53844352 | CS |
| 4 | -0.39415 | -44.5342071069 | 0.88505 | 1.03 | 0.4967 | 538668 | 0.65954002 | CS |
| 12 | -0.2391 | -32.7534246575 | 0.73 | 1.05 | 0.4967 | 320433 | 0.74010566 | CS |
| 26 | -0.278 | -36.1555468852 | 0.7689 | 1.05 | 0.4967 | 316495 | 0.74331409 | CS |
| 52 | -1.4791 | -75.0812182741 | 1.97 | 2.485 | 0.4967 | 795649 | 0.81846171 | CS |
| 156 | -17.6691 | -97.2968061674 | 18.16 | 20.68 | 0.4967 | 696338 | 3.51826357 | CS |
| 260 | -0.0753 | -13.2991875662 | 0.5662 | 48.96 | 0.4967 | 565954 | 7.36537842 | CS |
Support: +44 (0) 203 8794 460 | support@advfn.de
Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen
Premium
